Semjon Willier
Impact in
- Oncology top 5%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
Papers in
- Oncology 12
- CAR-T cell therapy research 12
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 2
- Co-authors
- Thomas G. P. Grünewald (5 shared papers)Tobias Feuchtinger (17 shared papers)Theresa Kaeuferle (13 shared papers)Franziska Blaeschke (13 shared papers)Elke Butt (3 shared papers)Dana Stenger (10 shared papers)Ramin Lotfi (3 shared papers)Judith Feucht (4 shared papers)
- Journals
- Blood (5 papers)Biology of the Cell (3 papers)Molecular Therapy (2 papers)Journal of Hematology & Oncology (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Semjon Willier
19 papers receiving 718 citations
Peers
Comparison fields: 5 of 59
- Oncology 415
- Immunology 164
- Hematology 53
- Molecular Biology 325
- Genetics 119
Countries citing papers authored by Semjon Willier
This map shows the geographic impact of Semjon Willier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semjon Willier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semjon Willier more than expected).
Fields of papers citing papers by Semjon Willier
This network shows the impact of papers produced by Semjon Willier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semjon Willier. The network helps show where Semjon Willier may publish in the future.
Co-authors
The 25 scholars most cited alongside Semjon Willier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2013 | 125 | |
| 3 | 2018 | 123 | |
| 4 | 2019 | 100 | |
| 5 | 2020 | 57 | |
| 6 | 2020 | 36 | |
| 7 | 2011 | 32 | |
| 8 | 2019 | 32 | |
| 9 | 2013 | 25 | |
| 10 | 2020 | 22 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2019 | 7 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2018 | 0 |
About Semjon Willier
Semjon Willier is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Epidemiology, having authored 21 papers that have together received 731 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Nausea and vomiting management (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Virus-based gene therapy research (2 papers), Immune Cell Function and Interaction (2 papers), CRISPR and Genetic Engineering (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (415 citations), Immunology (164 citations), Hematology (53 citations), Molecular Biology (325 citations) and Genetics (119 citations). Semjon Willier has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Thomas G. P. Grünewald, Tobias Feuchtinger, Theresa Kaeuferle, Franziska Blaeschke, Elke Butt, Dana Stenger, Ramin Lotfi, Judith Feucht, Michaela Döring and Andrew Kaiser. Their work appears in journals such as Blood, Biology of the Cell, Molecular Therapy, Journal of Hematology & Oncology and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.